Recherche
-
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International Cohorts
(CNS drugs. vol. 35, n° 11, pp. 1217-1232, 2021-11)Article de revue -
A meta-analysis comparing first-line immunosuppressants in neuromyelitis optica
(Annals of Clinical and Translational Neurology. vol. 8, n° 10, pp. 2025-2037, 2021-10)Article de revueLibre accès -
Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
(Neurotherapeutics. vol. 18, n° 1, pp. 378-386, 2021-01)Article de revueLibre accès -
Untreated patients with multiple sclerosis: a study of French expert centers
(European Journal of Neurology. vol. 28, n° 6, pp. 2026-2036, 2021-06)Article de revueLibre accès -
Determinants of therapeutic lag in multiple sclerosis
(Multiple Sclerosis Journal. vol. 27, n° 12, pp. 1838-1851, 2021-10)Article de revueLibre accès